Achieving very low LDL-C tied to lower risk of MI, stroke, and death with no safety concerns: FOURIER-OLE analysis Medha Baranwal16 Feb 2023 5:15 AM GMTUSA: Long-term achievement of lower LDL-C levels, down to <20 mg/dL, is associated with a reduced risk of cardiovascular (CV) outcomes and no...
Strawberry consumption linked with potential heart health and cardiometabolic benefits Dr. Kamal Kant Kohli13 Feb 2023 6:30 AM GMTResearchers have found in a new study that Strawberry consumption is linked with potential heart health and cardiometabolic benefits. This research...
Lomitapide significantly lowers LDLC in children with homozygous familial hypercholesterolemia: phase 3 trial topline results Dr. Kamal Kant Kohli8 Jan 2023 2:30 PM GMTAccording to topline results from a phase 3 trial, Lomitapide was associated with statistically significant reductions in low-density lipoprotein...
Lipid treatment intervention as early as 17 years of age may reverse atherosclerosis progression Dr. Kamal Kant Kohli18 Nov 2022 5:45 AM GMTIt is well known that abnormal blood cholesterol and triglyceride levels known as elevated lipids and dyslipidemia are major causes of atherosclerosis...
Sun Pharma arm to unveil Bempedoic Acid under brand name Brillo in India Roshni Dhar19 May 2022 12:45 PM GMTPharma major, Sun Pharmaceutical Industries Limited, has recently announced that one of its wholly-owned subsidiaries plans to launch a first-in-class...
Sun Pharma arm to launch Bempedoic Acid to treat bad cholesterol in India Ruchika Sharma19 May 2022 5:30 AM GMTBrillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents.
Statin Use not Linked with Risk of Dementia in FH Patients: JAMAÂ MD Bureau25 April 2022 4:45 AM GMTDementia is one of the major causes of disability worldwide, affecting approximately 50 million people, with nearly 10 million new cases yearly....
Polypill Shows LDL Lowering Advantage in High risk Primary Prevention Patients Dr. Nandita Mohan19 March 2022 11:00 AM GMTCardiovascular polypills are important as a fixed-dose combination of medications with proven benefits for the prevention of cardiovascular disease by...
Link between LDL-C lowering by statins and CVD reduction not consistent says JAMA study Dr. Kamal Kant Kohli16 March 2022 4:15 AM GMTResearchers at RCSI University of Medicine and Health Sciences have found in a new study that the link between 'bad' cholesterol (LDL-C) and poor...
Ezetimibe with statin therapy reduces risk of CV events even in patients with low LDL-C: Study Medha Baranwal7 Oct 2021 4:30 AM GMTUSA: According to a recent study in the Journal of the American College of Cardiology (JACC), ezetimibe addition to statin consistently reduces the...
Low-carb diet not tied to adverse LDL cholesterol levels inspite of high saturated fat levels Hina Zahid30 Sep 2021 3:30 AM GMTBOSTON - Boston Children's Hospital researchers have found in one of the largest study that low-carb diets - even though higher in saturated fat...
FDA approves evolocumab for pediatric patients Hina Zahid28 Sep 2021 1:00 PM GMTFDA has approved Repatha (evolocumab) injection as an add-on treatment to diet alone or together with certain other therapies for patients aged 10...
